Risk factor
Strong & resilient to price shocks
Profitability factor
Very low or no dividends
About
MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It offers pharmaceutical and wellness products, including medicines, vitamins, medical devices, and test kits; fast-moving consumer goods, such as toiletries, baby care products, soaps, detergents, and sanitizers. The company also provides wholesale cash and carry, and pathological laboratory testing...
Company Valuation
Based on key historical and expected multiples, the stock is overvalued relative to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EBITD.
Target Price
The average target price of MEDPLUS.NS is 1088 and suggests 31% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to
Buy
Sell